valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

PENNANTPARK INVESTMENT CORP (PNNT) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$2.50 ComplexityHigh Updated
$1.60 $6.67
bear $1.60 base $4.50 bull $6.67 margin of safety $2.50 market price* $3.04
PennantPark Investment Corporation is an externally managed business development company. It lends to and invests in middle-market U.S. companies and is required by tax rules to pay out nearly all of its taxable income. At June 30, 2026 it held about $924 million of real investments across 159 companies (the reported $1.19 billion also includes $269 million of U.S. Treasury bills bought at quarter-end with cash that had not yet settled; the two offset and are ignored here). The mix matters: first-lien loans are only about $425 million. Another $209 million is subordinated debt, most of it in the PennantPark Senior Loan Fund joint venture, and $275 million is preferred and common equity. That equity equals about 64% of shareholders' net assets, so swings in the value of those stakes, not loan defaults, have driven most of the company's results. Only four loans are on non-accrual (0.8% of fair value). How we measured earnings: for a lender, operating cash flow mostly reflects buying and selling loans, so we use what shareholders actually earn each year. That is net investment income (interest, dividends and fees less interest, fees and expenses) plus or minus realized and unrealized gains and losses. Borrowing is the raw material of a lending business, so interest is treated as an operating cost. It is already deducted in these earnings, and we do not subtract the debt a second time. The record since fiscal 2018 is $0.68, $0.24, -$0.24, $2.48 (the post-COVID rebound), -$0.37, -$0.52, $0.75 and $0.50 per share, plus $0.17 in the first nine months of fiscal 2026. Over that period net asset value per share fell from $9.10 (September 2017) to $6.56 (June 2026). The company pays out its investment income, so gains and losses flow straight into net asset value. Across the full cycle, including COVID, the 2022-2023 equity write-downs and the recovery since, the fund earned about 5% a year on net asset value. Investment losses averaged about 3.4% of net asset value a year. Because the business is now almost 30% smaller per share than in 2017, we measure earning power against today's $6.56 of net assets, not against the larger per-share dollar figures of past years. Debt: the fund owes $551.5 million: $311.5 million on its Truist credit facility (SOFR + 2.10%, about 5.9%, due December 2030, with $223.5 million undrawn), $165 million of 4.00% notes due November 1, 2026, and $75 million of 7.00% notes due 2029. That is about 1.28 times net assets, against a legal limit of 2.0 times (asset coverage of 178% versus the 150% minimum). The cheap 4.00% notes are being replaced. Since June the company has issued $62 million of 8.00% notes due 2031 (8.5% effective cost) and $2 million of 7.25% notes, and it has registered a further unsecured note series. Refinancing the $165 million at a blend of the new notes and the credit line raises interest cost by roughly $4.6 million a year, about $0.06 per share after the lower incentive fee. The May 2026 4.50% notes were already repaid with the credit line and the 7% 2029 notes. That cost is largely in the June quarter's results. Base case ($4.50 per share): net investment income was $0.14 per share in the June quarter, or about $0.54 a year. After the note refinancing it is about $0.48. Investment losses run at about $0.21 per share a year, or 3.2% of net asset value. That is between the 2.2-4.1% of the last three years and the 3.4% full-cycle average. Earnings are about $0.27 per share, held flat indefinitely. That is below fiscal 2025's $0.50, which fell 33% from fiscal 2024, and in line with the three most recent quarters. The adviser has run this vehicle since 2007 and the portfolio is continuously re-lent, so we let that stream continue. We credit no portfolio growth. The planned rotation out of equity into income-producing loans would lift income, but it has not happened yet, so we do not count it. Bear case ($1.60 per share): a two-year stress like fiscal 2022-2023, when losses on the equity book and weaker credits cost about 13% of net asset value a year. The refinancing is done entirely at the 8.5% cost of the new 2031 notes. Earnings are about -$0.40 and -$0.35 per share, and net asset value falls to about $4.97. Leverage then reaches about 1.7 times, with asset coverage near 159%. That is still above the legal floor, but it would force asset sales and limit distributions. After that the fund earns about 3% on its smaller net assets, roughly $0.155 per share a year. Interest stays well covered by investment income throughout, so the debt does not threaten solvency in this case. Bull case ($6.67 per share): the refinancing is done at the 5.9% credit-line rate, keeping net investment income near $0.50. Losses stay low, at about 1.5% of net asset value ($0.10 per share), helped by equity exits like this year's realization of an equity co-investment in a defense-technology company. Earnings of about $0.40 a year are a 6% return on net assets, close to fiscal 2018 and fiscal 2025. We did not credit the July 2026 repricing of the joint venture's securitization (from SOFR + 2.66% to SOFR + 1.69% on part of its debt). It helps, but the filings do not give its size. Values against debt: because interest is already inside earnings, each case above is the value to shareholders after the lenders, and the debt is not subtracted again. In total, the base case values the business (portfolio plus cash) at about $845 million, against about $963 million reported. The fund owes $551.5 million, which leaves about $294 million, or $4.50 per share, for shareholders. On the same basis the bear case leaves about $105 million after debt and the bull case about $435 million. What would make this wrong: another round of large write-downs in the equity book, given its 64% share of net assets. Lower short-term rates would cut income on a book that is 87% floating-rate. A faster, successful rotation from equity into loans, or sustained low losses, would push results toward the bull case. Change from our previous view: we previously valued the shares at $7.00 (base), $2.43 (bear) and $10.00 (bull). Three things lowered the estimates. First, the earlier view applied past per-share earnings to a fund that is now smaller per share. Second, it described the book as mostly senior loans, when equity is almost two-thirds of net assets. Third, it did not account for the November 2026 notes being refinanced at roughly double their 4% coupon. Two newly identified facts helped: the quarter-end payable is offset by Treasury bills rather than being added leverage, and the joint venture has cut its borrowing cost. Because the shares are levered, externally managed, heavily exposed to equity marks, and have lost net asset value per share over the past decade, the margin-of-safety price is around $2.50. That is about 45% below the base value and above the bear case.
Fiscal yearOwner's earningsMethodology
2025 $0.51 ▼
BDC basis: NAV 7.56 -> 7.11 + distributions 0.96 = 0.51. NII 46.1M (0.705/sh on 65.3M diluted shares). Source: FY2025 10-K accession 0001193125-25-293703.
2024 $0.74 ▼
BDC basis: NAV 7.70 -> 7.56 + distributions 0.88 = 0.74. NII 60.1M (0.92/sh). Source: FY2024 10-K accession 0000950170-24-130670; FY2025 10-K 0001193125-25-293703.
2023 -$0.52 ▼
BDC basis: NAV 8.98 -> 7.70 + distributions 0.76 = -0.52. NII 65.5M (1.005/sh on 65.2M diluted shares). Source: FY2023 10-K accession 0000950170-23-068909; FY2025 10-K 0001193125-25-293703.
2022 -$0.31 ▼
BDC basis (see FY2021): NAV 9.85 -> 8.98 + distributions 0.56 = -0.31. NII was 43.9M (~0.66/sh) but net losses on portfolio exceeded it. Source: FY2022 10-K accession 0000950170-22-025352; FY2025 10-K 0001193125-25-293703.
2021 $2.49 ▼
BDC: CFO is dominated by portfolio purchases/sales so not usable. OE/sh = NII/sh less net realized+unrealized losses = change in NAV/sh + distributions/sh (share count ~flat; no SBC, externally managed; fees and interest already inside NII). NAV 7.84 (9/30/20) -> 9.85 (9/30/21) + distributions 0.48 = 2.49. Rebound year after COVID marks. Sources: FY2022 10-K accession 0000950170-22-025352; FY2025 10-K 0001193125-25-293703.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (nationwide; loans to and equity in middle-market U.S. companies across the Northeast, Midwest, West and South)
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis
A chartist would see a steep, persistent downtrend. The shares have roughly halved over the past year, from a 52-week high near $6.80 to about $3.30, and are trading just above the 52-week low of about $3.19, with no base or reversal pattern yet. A chartist would treat the low-$3 area as support that has to hold. A break below it would signal further downside, and it would take a sustained recovery well above current levels before anyone called the trend turned.
Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.